|
| Status |
Public on Dec 28, 2015 |
| Title |
BC3 control rep 2 |
| Sample type |
RNA |
| |
|
| Source name |
BC3 cell line
|
| Organism |
Homo sapiens |
| Characteristics |
cell line: BC3
treatment: DMSO
|
| Treatment protocol |
DMSO or 5uM lenalidomide added to media
|
| Growth protocol |
Identical culture media save for treatment (DMSO or lenalidomide)
|
| Extracted molecule |
total RNA |
| Extraction protocol |
Standard as recommended by Illumina
|
| Label |
Cy3
|
| Label protocol |
Standard as recommended by Illumina
|
| |
|
| Hybridization protocol |
Standard Illumina hybridization protocol
|
| Scan protocol |
Standard Illumina scanning protocol
|
| Description |
BC3 control rep 2
|
| Data processing |
The data were normalised using limma::neqc() background correction and quantile normalisation in R
|
| |
|
| Submission date |
Aug 21, 2014 |
| Last update date |
Dec 28, 2015 |
| Contact name |
Timothy J. Triche |
| Phone |
(323) 442-8072
|
| Organization name |
University of Southern California, Keck School of Medicine
|
| Department |
Norris Comprehensive Cancer Center
|
| Lab |
Hematology
|
| Street address |
1450 Biggy St., Harlyne Norris Research Tower 3509
|
| City |
Los Angeles |
| State/province |
CA |
| ZIP/Postal code |
90033 |
| Country |
USA |
| |
|
| Platform ID |
GPL10558 |
| Series (1) |
| GSE60618 |
Treatment of primary effusion lymphoma cell lines with lenalidomide |
|
